William A. Haseltine, Contributor

Author's posts

Pain, Pain Go Away: New Non-Addictive Painkiller Shows Promise In Early Trials

A novel class of non-addictive painkillers may be just around the corner, offering a much-needed alternative to opioids.

Building The Brain-Machine Connection: Deciphering Thoughts For Action

New cortical brain-machine interface technologies will soon aid those with brain injury or neurodegenerative diseases to improve basic motor function.

A Different Kind Of Cancer Killer: Improving CAR NK Cell Therapy

One study discovers why CAR NK cells lose steam over time and suggests a way to rejuvenate their cancer-killing ability.

Rejuvenating Old Brains: Platelet Factor 4 (PF4)

As we age, so does our brain. There’s no way around it. Or is there? New research has identified a small protein that seemingly returns youth to aging brains.

Can We Turn Back The Clock? Parabiosis Research Suggests Yes

Aging is considered a given; a natural and inevitable part of life. Researchers at Harvard Medical School are pushing back. Age, their work suggests, may be reversible.

A Sight To Behold: Correcting Vision With Glasses, Contacts, And LASIK

Over 2 billion people around the globe have impairments that affect their ability to see. One billion of those people have issues that could have been prevented.

Wastewater Analysis Update On BA.2.86 In The United States: It’s Here, Be Careful

The latest iteration of Omicron, BA.2.86, is here, and we must be ready for its arrival.

What To Know About The New RSV Vaccines

Three new RSV vaccines and one new monoclonal antibody RSV treatment for infants have been approved by the FDA as we approach peak season for the virus.

What To Know About The New RSV Vaccines

Three new RSV vaccines and one new monoclonal antibody RSV treatment for infants have been approved by the FDA as we approach peak season for the virus.

Covid-19: The Shapeshifting Protean Virus

A new variant of SARS-CoV-2, BA.2.86, may spark the latest wave of Covid-19.